Andrew Tsai covers small- to mid-cap biotech companies at Jefferies and has 9 years of equity research experience. He joined Jefferies in May 2017 and became a covering Analyst in early 2019. Prior to Jefferies, he gained equity research experience in the biotechnology and software sectors at Wells Fargo, RBC Capital Markets, and Wedbush Securities. Andrew received his BA in Environmental Engineering from UC Irvine and his MS in Civil & Environmental Engineering from Stanford University.